EP 155: AI's Edge in Pharma - Lowering Drug Failure Rates

Why do drugs fail at such a high rate? What can AI do about? We're asking an expert helping to lead the Pharma industry. Chris Gibson, Co-Founder and CEO at Recursion, joins us to discuss how GenAI is reshaping the Pharma industry and medical drugs.Newsletter: Sign up for our free daily newsletterMore on this Episode: Episode PageJoin the discussion: Ask Chris and Jordan questions about AI and PharmaUpcoming Episodes: Check out the upcoming Everyday AI Livestream lineupWebsite: YourEverydayAI.comEmail The Show: [email protected]

Connect with Jordan on LinkedInTimestamps:[00:01:15] Daily AI news[00:04:00] About Chris and Recursion[00:06:30] Impact of AI and reducing drug failure[00:12:15] Work being done in drug testing and AI [00:16:45] LLMs being used in Pharma [00:19:10] Challenges with data[00:23:20] Future of medicine with AI[00:26:20] Chris' final takeawayTopics Covered in This Episode:1. Why drugs fail at a high rate2. Work being done in drug testing3. AI's impact on drug research4. How AI and drug testing work5. Future of medicine with AIKeywords:AI, artificial intelligence, drug failure rates, Amazon, reInvent 2023 conference, Titan AI image generator, DeepMind, chemical materials, computer chips, solar panel, ChatGPT, Sam Altman, OpenAI, Microsoft, pharmaceutical industry, clinical trials, FDA approval process, data problem, technology tools, large language models, molecules, Trillions of relationships, public data set, Amazon Prime, healthcare, preventative medicine, AGI, mission-driven AI, Recursion, everyday AI show.Send Everyday AI and Jordan a text message. (We can't reply back unless you leave contact info) Start Here ▶️Not sure where to start when it comes to AI? Start with our Start Here Series. You can listen to the first drop -- Episode 691 -- or get free access to our Inner Cricle community and all episodes: StartHereSeries.com Also, here's a link to the entire series on a Spotify playlist.